Richard Pilot
About Richard Pilot
Richard Pilot is the Executive Director at Bristol Myers Squibb in Summit, NJ, with over 30 years of experience in safety and medical affairs. He has held various senior roles at Celgene, Novartis, and Roche, and holds multiple advanced degrees in public health and medicine.
Current Position at Bristol Myers Squibb
Richard Pilot currently serves as the Executive Director at Bristol Myers Squibb, based in Summit, NJ. He has been with the company since October 2013, leveraging his extensive experience in safety and medical affairs to support high-priority programs. His role involves strategic vision and people management, particularly in areas with high unmet needs such as oncology and hematology.
Previous Role at Celgene
Before joining Bristol Myers Squibb, Richard Pilot was the Senior Director of Safety and Risk Management at Celgene from 2010 to 2013. In this role, he was responsible for overseeing safety protocols and risk management strategies, ensuring patient safety and regulatory compliance.
Executive Experience at Novartis
From 2004 to 2010, Richard Pilot held the position of Executive Director at Novartis in East Hanover, NJ. His tenure at Novartis was marked by significant contributions to drug safety and medical affairs, where he utilized his expertise to enhance the company’s safety strategies and operational efficiency.
Early Career at Roche
Richard Pilot began his career at Roche, where he worked for a total of 15 years in various capacities. He started as a Drug Safety Physician in Germany from 1989 to 1993, before moving to Basel, Switzerland as a Drug Safety Physician and Safety Expert from 1993 to 1999. He then transferred to Nutley, NJ, continuing his role as a Drug Safety Physician from 1999 to 2004.
Educational Background in Public Health and Medicine
Richard Pilot has a robust educational background in public health and medicine. He earned his MD from Albert-Ludwigs-Universität Freiburg im Breisgau, studying from 1978 to 1984. He also holds a Master of Public Health (M.P.H.) from the University of Zurich School of Public Health, achieved from 1996 to 1999. Additionally, he completed a Master of Science (MS) in Epidemiology from Columbia University School of Public Health, studying from 2000 to 2006. Moreover, he is a Fellow of the Faculty of Pharmaceutical Medicine from the University of Cardiff School of Pharmacy, completed from 1991 to 1994.